Detail page

Knowledge Web

Person

Aysel Ahadova (1988-)

Name	Aysel Ahadova
Time	1988- (Date of birth and death)
Place	Baku (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Dr. sc. hum. (an der Medizinischen Fakultät der Universität Heidelberg) (2015)
Variant	Aysel I. Ahadova
Related	Klinikum Heidelberg Universität Heidelberg. Pathologisches Institut
Further information	Tumorbiologie mikrosatelliten-intabiler (MSI) Tumoren, Angewandte Tumorbiologie, Pathologisches Institut, Universitätsklinikum Heidelberg
Record type	Person
GND-Identifier	106835268X
Record ID	106835268X
Involved in show all Tumour mutational burden: clinical utility, challenges and emerging improvements Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement Liquid biopsy-based early tumor and minimal residual disease detection: New perspectives for cancer predisposition syndromes Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers Correction to: The majority of β-catenin mutations in colorectal cancer is homozygous The majority of β-catenin mutations in colorectal cancer is homozygous Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome Mechanisms of action of 2-deoxy-D-glucose in cancer cells and evaluation of novel approaches of application

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Aysel Ahadova (1988-)

Tumour mutational burden: clinical utility, challenges and emerging improvements

Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement

Liquid biopsy-based early tumor and minimal residual disease detection: New perspectives for cancer predisposition syndromes

Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium

Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers

Correction to: The majority of β-catenin mutations in colorectal cancer is homozygous

The majority of β-catenin mutations in colorectal cancer is homozygous

Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report

CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome

Mechanisms of action of 2-deoxy-D-glucose in cancer cells and evaluation of novel approaches of application